Cargando…
Mucormycosis in 2023: an update on pathogenesis and management
Mucormycosis (MCR) is an emerging and frequently lethal fungal infection caused by the Mucorales family, with Rhizopus, Mucor, and Lichtheimia, accounting for > 90% of all cases. MCR is seen in patients with severe immunosuppression such as those with hematologic malignancy or transplantation, Di...
Autores principales: | Alqarihi, Abdullah, Kontoyiannis, Dimitrios P., Ibrahim, Ashraf S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552646/ https://www.ncbi.nlm.nih.gov/pubmed/37808914 http://dx.doi.org/10.3389/fcimb.2023.1254919 |
Ejemplares similares
-
Pulmonary Mucormycosis as the Leading Clinical Type of Mucormycosis in Western China
por: Qu, Junyan, et al.
Publicado: (2021) -
Editorial: Research advances in mucormycosis
por: Singh, Rachna
Publicado: (2023) -
Recent Advances and Future Directions in the Understanding of Mucormycosis
por: Garre, Victoriano
Publicado: (2022) -
Mucormycosis in the COVID-19 Environment: A Multifaceted Complication
por: Sharma, Rohit, et al.
Publicado: (2022) -
Amphotericin B colloidal dispersion: an effective drug for the treatment of mucormycosis in China
por: Liu, Juntao, et al.
Publicado: (2023)